캐리어 스크리닝 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2035년)

Carrier Screening Market - Scope of Report

TMR's report on the global carrier screening market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global carrier screening market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global carrier screening market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the carrier screening market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global carrier screening market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global carrier screening market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global carrier screening market.

The report delves into the competitive landscape of the global carrier screening market. Key players operating in the global carrier screening market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global carrier screening market profiled in this report.

Key Questions Answered in Global carrier screening market Report:

• What is the sales/revenue generated by carrier screening across all regions during the forecast period?
• What are the opportunities in the global carrier screening market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Carrier Screening Market - Research Objectives and Research Approach

The comprehensive report on the global carrier screening market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global carrier screening market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global carrier screening market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Carrier Screening Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Carrier Screening Market Analysis and Forecast, 2020-2035
  • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

• 5.1. Key Industry Events
• 5.2. PORTER's Five Forces Analysis
• 5.3. Supply Chain Analysis
• 5.4. PESTLE Analysis
• 5.5. Technological Advancements
• 5.6. Unmet Needs of the Market
• 5.7. Epidemiology of Diseases

6. Global Carrier Screening Market Analysis and Forecast, by Type

• 6.1. Introduction & Definition
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Type, 2020-2035
  • 6.3.1. Expanded Carrier Screening
  • 6.3.2. Targeted Disease Carrier Screening
• 6.4. Market Attractiveness Analysis, by Type

7. Global Carrier Screening Market Analysis and Forecast, by Sample Type

• 7.1. Introduction & Definition
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by Sample Type, 2020-2035
  • 7.3.1. Blood
  • 7.3.2. Saliva
  • 7.3.3. Others
• 7.4. Market Attractiveness Analysis, by Sample Type

8. Global Carrier Screening Market Analysis and Forecast, by Technique

• 8.1. Introduction & Definition
• 8.2. Key Findings/Developments
• 8.3. Market Value Forecast, by Technique, 2020-2035
  • 8.3.1. DNA Sequencing
  • 8.3.2. Polymerase Chain Reaction
  • 8.3.3. Microarrays
  • 8.3.4. Others
• 8.4. Market Attractiveness Analysis, by Technique

9. Global Carrier Screening Market Analysis and Forecast, by Application

• 9.1. Introduction & Definition
• 9.2. Key Findings/Developments
• 9.3. Market Value Forecast, by Application, 2020-2035
  • 9.3.1. Cystic Fibrosis
  • 9.3.2. Tay-Sachs
  • 9.3.3. Gaucher Disease
  • 9.3.4. Sickle Cell Disease
  • 9.3.5. Others
• 9.4. Market Attractiveness Analysis, by Application

10. Global Carrier Screening Market Analysis and Forecast, by End-user

• 10.1. Introduction & Definition
• 10.2. Key Findings/Developments
• 10.3. Market Value Forecast, by End-user, 2020-2035
  • 10.3.1. Hospitals & Clinics
  • 10.3.2. Reference Laboratories
  • 10.3.3. Others
• 10.4. Market Attractiveness Analysis, by End-user

11. Global Carrier Screening Market Analysis and Forecast, by Region

• 11.1. Key Findings
• 11.2. Market Value Forecast, by Region, 2020-2035
  • 11.2.1. North America
  • 11.2.2. Europe
  • 11.2.3. Asia Pacific
  • 11.2.4. Latin America
  • 11.2.5. Middle East & Africa
• 11.3. Market Attractiveness Analysis, by Region

12. North America Carrier Screening Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Type, 2020-2035
  • 12.2.1. Expanded Carrier Screening
  • 12.2.2. Targeted Disease Carrier Screening
• 12.3. Market Value Forecast, by Sample Type, 2020-2035
  • 12.3.1. Blood
  • 12.3.2. Saliva
  • 12.3.3. Others
• 12.4. Market Value Forecast, by Technique, 2020-2035
  • 12.4.1. DNA Sequencing
  • 12.4.2. Polymerase Chain Reaction
  • 12.4.3. Microarrays
  • 12.4.4. Others
• 12.5. Market Value Forecast, by Application, 2020-2035
  • 12.5.1. Cystic Fibrosis
  • 12.5.2. Tay-Sachs
  • 12.5.3. Gaucher Disease
  • 12.5.4. Sickle Cell Disease
  • 12.5.5. Others
• 12.6. Market Value Forecast, by End-user, 2020-2035
  • 12.6.1. Hospitals & Clinics
  • 12.6.2. Reference Laboratories
  • 12.6.3. Others
• 12.7. Market Value Forecast, by Country, 2020-2035
  • 12.7.1. U.S.
  • 12.7.2. Canada
• 12.8. Market Attractiveness Analysis
  • 12.8.1. By Type
  • 12.8.2. By Sample Type
  • 12.8.3. By Technique
  • 12.8.4. By Application
  • 12.8.5. By End-user
  • 12.8.6. By Country

13. Europe Carrier Screening Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Type, 2020-2035
  • 13.2.1. Expanded Carrier Screening
  • 13.2.2. Targeted Disease Carrier Screening
• 13.3. Market Value Forecast, by Sample Type, 2020-2035
  • 13.3.1. Blood
  • 13.3.2. Saliva
  • 13.3.3. Others
• 13.4. Market Value Forecast, by Technique, 2020-2035
  • 13.4.1. DNA Sequencing
  • 13.4.2. Polymerase Chain Reaction
  • 13.4.3. Microarrays
  • 13.4.4. Others
• 13.5. Market Value Forecast, by Application, 2020-2035
  • 13.5.1. Cystic Fibrosis
  • 13.5.2. Tay-Sachs
  • 13.5.3. Gaucher Disease
  • 13.5.4. Sickle Cell Disease
  • 13.5.5. Others
• 13.6. Market Value Forecast, by End-user, 2020-2035
  • 13.6.1. Hospitals & Clinics
  • 13.6.2. Reference Laboratories
  • 13.6.3. Others
• 13.7. Market Value Forecast, by Country/Sub-region, 2020-2035
  • 13.7.1. Germany
  • 13.7.2. UK
  • 13.7.3. France
  • 13.7.4. Italy
  • 13.7.5. Spain
  • 13.7.6. Rest of Europe
• 13.8. Market Attractiveness Analysis
  • 13.8.1. By Type
  • 13.8.2. By Sample Type
  • 13.8.3. By Technique
  • 13.8.4. By Application
  • 13.8.5. By End-user
  • 13.8.6. By Country/Sub-region

14. Asia Pacific Carrier Screening Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast, by Type, 2020-2035
  • 14.2.1. Expanded Carrier Screening
  • 14.2.2. Targeted Disease Carrier Screening
• 14.3. Market Value Forecast, by Sample Type, 2020-2035
  • 14.3.1. Blood
  • 14.3.2. Saliva
  • 14.3.3. Others
• 14.4. Market Value Forecast, by Technique, 2020-2035
  • 14.4.1. DNA Sequencing
  • 14.4.2. Polymerase Chain Reaction
  • 14.4.3. Microarrays
  • 14.4.4. Others
• 14.5. Market Value Forecast, by Application, 2020-2035
  • 14.5.1. Cystic Fibrosis
  • 14.5.2. Tay-Sachs
  • 14.5.3. Gaucher Disease
  • 14.5.4. Sickle Cell Disease
  • 14.5.5. Others
• 14.6. Market Value Forecast, by End-user, 2020-2035
  • 14.6.1. Hospitals & Clinics
  • 14.6.2. Reference Laboratories
  • 14.6.3. Others
• 14.7. Market Value Forecast, by Country/Sub-region, 2020-2035
  • 14.7.1. China
  • 14.7.2. Japan
  • 14.7.3. India
  • 14.7.4. Australia & New Zealand
  • 14.7.5. Rest of Asia Pacific
• 14.8. Market Attractiveness Analysis
  • 14.8.1. By Type
  • 14.8.2. By Sample Type
  • 14.8.3. By Technique
  • 14.8.4. By Application
  • 14.8.5. By End-user
  • 14.8.6. By Country/Sub-region

15. Latin America Carrier Screening Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast, by Type, 2020-2035
  • 15.2.1. Expanded Carrier Screening
  • 15.2.2. Targeted Disease Carrier Screening
• 15.3. Market Value Forecast, by Sample Type, 2020-2035
  • 15.3.1. Blood
  • 15.3.2. Saliva
  • 15.3.3. Others
• 15.4. Market Value Forecast, by Technique, 2020-2035
  • 15.4.1. DNA Sequencing
  • 15.4.2. Polymerase Chain Reaction
  • 15.4.3. Microarrays
  • 15.4.4. Others
• 15.5. Market Value Forecast, by Application, 2020-2035
  • 15.5.1. Cystic Fibrosis
  • 15.5.2. Tay-Sachs
  • 15.5.3. Gaucher Disease
  • 15.5.4. Sickle Cell Disease
  • 15.5.5. Others
• 15.6. Market Value Forecast, by End-user, 2020-2035
  • 15.6.1. Hospitals & Clinics
  • 15.6.2. Reference Laboratories
  • 15.6.3. Others
• 15.7. Market Value Forecast, by Country/Sub-region, 2020-2035
  • 15.7.1. Brazil
  • 15.7.2. Mexico
  • 15.7.3. Rest of Latin America
• 15.8. Market Attractiveness Analysis
  • 15.8.1. By Type
  • 15.8.2. By Sample Type
  • 15.8.3. By Technique
  • 15.8.4. By Application
  • 15.8.5. By End-user
  • 15.8.6. By Country/Sub-region

16. Middle East & Africa Carrier Screening Market Analysis and Forecast

• 16.1. Introduction
  • 16.1.1. Key Findings
• 16.2. Market Value Forecast, by Type, 2020-2035
  • 16.2.1. Expanded Carrier Screening
  • 16.2.2. Targeted Disease Carrier Screening
• 16.3. Market Value Forecast, by Sample Type, 2020-2035
  • 16.3.1. Blood
  • 16.3.2. Saliva
  • 16.3.3. Others
• 16.4. Market Value Forecast, by Technique, 2020-2035
  • 16.4.1. DNA Sequencing
  • 16.4.2. Polymerase Chain Reaction
  • 16.4.3. Microarrays
  • 16.4.4. Others
• 16.5. Market Value Forecast, by Application, 2020-2035
  • 16.5.1. Cystic Fibrosis
  • 16.5.2. Tay-Sachs
  • 16.5.3. Gaucher Disease
  • 16.5.4. Sickle Cell Disease
  • 16.5.5. Others
• 16.6. Market Value Forecast, by End-user, 2020-2035
  • 16.6.1. Hospitals & Clinics
  • 16.6.2. Reference Laboratories
  • 16.6.3. Others
• 16.7. Market Value Forecast, by Country/Sub-region, 2020-2035
  • 16.7.1. GCC Countries
  • 16.7.2. South Africa
  • 16.7.3. Rest of Middle East & Africa
• 16.8. Market Attractiveness Analysis
  • 16.8.1. By Type
  • 16.8.2. By Sample Type
  • 16.8.3. By Technique
  • 16.8.4. By Application
  • 16.8.5. By End-user
  • 16.8.6. By Country/Sub-region

17. Competition Landscape

• 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 17.2. Market Share Analysis, by Company (2024)
• 17.3. Company Profiles
  • 17.3.1. Myriad Genetics, Inc.
    • 17.3.1.1. Company Overview
    • 17.3.1.2. Financial Overview
    • 17.3.1.3. Product Portfolio
    • 17.3.1.4. Business Strategies
    • 17.3.1.5. Recent Developments
  • 17.3.2. Cepheid
    • 17.3.2.1. Company Overview
    • 17.3.2.2. Financial Overview
    • 17.3.2.3. Product Portfolio
    • 17.3.2.4. Business Strategies
    • 17.3.2.5. Recent Developments
  • 17.3.3. Illumina
    • 17.3.3.1. Company Overview
    • 17.3.3.2. Financial Overview
    • 17.3.3.3. Product Portfolio
    • 17.3.3.4. Business Strategies
    • 17.3.3.5. Recent Developments
  • 17.3.4. Thermo Fisher Scientific, Inc.
    • 17.3.4.1. Company Overview
    • 17.3.4.2. Financial Overview
    • 17.3.4.3. Product Portfolio
    • 17.3.4.4. Business Strategies
    • 17.3.4.5. Recent Developments
  • 17.3.5. F.Hoffmann-La Roche Ltd
    • 17.3.5.1. Company Overview
    • 17.3.5.2. Financial Overview
    • 17.3.5.3. Product Portfolio
    • 17.3.5.4. Business Strategies
    • 17.3.5.5. Recent Developments
  • 17.3.6. LabCorp.
    • 17.3.6.1. Company Overview
    • 17.3.6.2. Financial Overview
    • 17.3.6.3. Product Portfolio
    • 17.3.6.4. Business Strategies
    • 17.3.6.5. Recent Developments
  • 17.3.7. Otogenetics
    • 17.3.7.1. Company Overview
    • 17.3.7.2. Financial Overview
    • 17.3.7.3. Product Portfolio
    • 17.3.7.4. Business Strategies
    • 17.3.7.5. Recent Developments
  • 17.3.8. MedGenome
    • 17.3.8.1. Company Overview
    • 17.3.8.2. Financial Overview
    • 17.3.8.3. Product Portfolio
    • 17.3.8.4. Business Strategies
    • 17.3.8.5. Recent Developments
  • 17.3.9. GeneTech
    • 17.3.9.1. Company Overview
    • 17.3.9.2. Financial Overview
    • 17.3.9.3. Product Portfolio
    • 17.3.9.4. Business Strategies
    • 17.3.9.5. Recent Developments
  • 17.3.10. Centogene N.V.
    • 17.3.10.1. Company Overview
    • 17.3.10.2. Financial Overview
    • 17.3.10.3. Product Portfolio
    • 17.3.10.4. Business Strategies
    • 17.3.10.5. Recent Developments
  • 17.3.11. Fulgent Genetics
    • 17.3.11.1. Company Overview
    • 17.3.11.2. Financial Overview
    • 17.3.11.3. Product Portfolio
    • 17.3.11.4. Business Strategies
    • 17.3.11.5. Recent Developments
  • 17.3.12. OPKO Health Inc.
    • 17.3.12.1. Company Overview
    • 17.3.12.2. Financial Overview
    • 17.3.12.3. Product Portfolio
    • 17.3.12.4. Business Strategies
    • 17.3.12.5. Recent Developments
  • 17.3.13. Quest Diagnostics Incorporated
    • 17.3.13.1. Company Overview
    • 17.3.13.2. Financial Overview
    • 17.3.13.3. Product Portfolio
    • 17.3.13.4. Business Strategies
    • 17.3.13.5. Recent Developments
  • 17.3.14. Natera Inc.
    • 17.3.14.1. Company Overview
    • 17.3.14.2. Financial Overview
    • 17.3.14.3. Product Portfolio
    • 17.3.14.4. Business Strategies
    • 17.3.14.5. Recent Developments